Literature DB >> 22250886

Patient perspectives on tobacco cessation services for persons living with HIV/AIDS.

William Robinson1, Sarah Moody-Thomas, Deann Gruber.   

Abstract

With the advent of highly active antiretroviral therapy, the survival for HIV-infected individuals has increased, but other health-related behaviors have been largely unaddressed. Tobacco use is of primary concern, given its prevalence and the medical implications of smoking among these patients. Improving responsiveness to the needs, values, and preferences of patients (i.e., patient-centeredness) is a focus for increasing participation in systems of care. To assess the social, cultural, and educational barriers limiting use of smoking cessation services by HIV-positive individuals, two focus groups were conducted at a Louisiana HIV outpatient clinic. Questions addressed smoking history, knowledge of and access to cessation services, and knowledge of effects of smoking on disease progression and medication efficacy. Identified themes included a desire for increased and more specific information on the health effects of smoking as related to the patients' HIV status, difficulty in quitting, motivation, and the increased burden of medication. These results provide recommendations for designing, for HIV-infected smokers, patient-centered treatment of tobacco use, including providing relevant knowledge, access to cessation services, and more effective messages related to the impact of tobacco use on disease progression.

Entities:  

Mesh:

Year:  2011        PMID: 22250886     DOI: 10.1080/09540121.2011.582078

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  9 in total

1.  Qualitative Exploration of a Smoking Cessation Trial for People Living With HIV in South Africa.

Authors:  Nandita Krishnan; Joel Gittelsohn; Alexandra Ross; Jessica Elf; Sandy Chon; Raymond Niaura; Neil Martinson; Jonathan E Golub
Journal:  Nicotine Tob Res       Date:  2018-08-14       Impact factor: 4.244

Review 2.  Smoking and HIV: prevalence, health risks, and cessation strategies.

Authors:  Alan R Lifson; Harry A Lando
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  Cessation-related information, motivation, and behavioral skills in smokers living with HIV.

Authors:  Daniel Shirley; Laura Thibodeau; Sheryl L Catz; Katryna McCoy; Douglas E Jorenby; Nasia Safdar; James M Sosman
Journal:  AIDS Care       Date:  2017-08-17

Review 4.  Exploring Issues of Comorbid Conditions in People Who Smoke.

Authors:  Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2016-01-17       Impact factor: 4.244

5.  Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative study.

Authors:  Kenneth L Morford; Srinivas B Muvvala; Philip A Chan; Deborah H Cornman; Molly Doernberg; Elizabeth Porter; Michael Virata; Jessica E Yager; David A Fiellin; E Jennifer Edelman
Journal:  J Subst Abuse Treat       Date:  2022-03-18

6.  Beliefs, experience, and interest in pharmacotherapy among smokers with HIV.

Authors:  Amy McQueen; Enbal Shacham; Walton Sumner; E Turner Overton
Journal:  Am J Health Behav       Date:  2014-03

7.  Patient perspectives on tobacco use treatment in primary care.

Authors:  Jacqueline R Halladay; Maihan Vu; Carol Ripley-Moffitt; Sachin K Gupta; Christine O'Meara; Adam O Goldstein
Journal:  Prev Chronic Dis       Date:  2015-02-05       Impact factor: 2.830

8.  HIV patients' perceptions of a potential multi-component mindfulness-based smoking cessation smartphone application intervention.

Authors:  Taghrid Asfar; Maria Luisa Alcaide; Deborah L Jones; Laura A McClure; Judson Brewer; David J Lee; Adam Carrico
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

Review 9.  How to practice person-centred care: A conceptual framework.

Authors:  Maria J Santana; Kimberly Manalili; Rachel J Jolley; Sandra Zelinsky; Hude Quan; Mingshan Lu
Journal:  Health Expect       Date:  2017-11-19       Impact factor: 3.377

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.